New Delhi, Mar 4, 2025: Apollo Hospitals has inked a partnership with Ion Beam Applications (IBA), a global Proton Beam Therapy (PBT) solutions provider, to introduce Proteus One system in India, defining a milestone in the country’s pursuit of excellence in cancer care.
This initiative will also facilitate knowledge-sharing and training for oncologists, enabling the widespread adoption of advanced treatment modalities across the region.
A pioneer in ushering in advanced oncology, Apollo Hospitals Enterprise Ltd introduced Proton Therapy to India in 2019 at Apollo Proton Cancer Centre, its futuristic cancer centre in Chennai — becoming the first and only Proton Therapy facility in South Asia and the Middle East. Since its inception, over 2,000 patients from 147 countries have benefited from this cutting-edge technology. Proton therapy is an effective treatment of tumors of the Central Nervous System, head and neck tumors, paediatric and urological, and complex cancers.
According to the studies, the global burden of cancer is projected to increase to 21.4 million incident cases by 2030. As per the study published in The Lancet Regional Health, worldwide in terms of absolute incidence number, following China and the US, India ranks third, contributing 7.5% of all new cancer incidences and is expected to grow to 1.5 million this year.
Dr Prathap C Reddy, Founder-Chairman, Apollo Hospitals Enterprise Ltd, said, “At Apollo, we are driven by an unyielding passion for excellence in healthcare. Our commitment is to ensure that India remains at the forefront of medical innovation, providing patients with access to the world’s most advanced treatments. The addition of Proteus One to our Apollo Proton Cancer Centres further solidifies our position as a global leader in Proton Therapy. This next-generation technology will allow us to achieve superior clinical outcomes and significantly improve the quality of life for cancer patients in India and beyond.”
Olivier Legrain, Chief Executive Officer of IBA, said, “These contracts expand upon the close relationship we have built for more than a decade with Apollo Hospitals. Seeing an existing customer reaffirming its confidence in our solutions not only demonstrates the reliability and superiority of the IBA portfolio but also highlights the level of excellence of the services we deliver. We look forward to further strengthening our relationship with Apollo as we enable more patients in India to gain access to this life-saving treatment modality.”
Preetha Reddy, Executive Vice Chairperson, Apollo Hospitals Enterprise Ltd, highlighted the broader vision behind this collaboration, stating, “Cancer care is evolving rapidly, and at Apollo, we remain steadfast in our mission to stay ahead of this evolution. The introduction of the Proteus One system is a significant leap towards personalized, precise, and highly effective treatment for cancer patients. Our partnership with IBA reflects our dedication to bringing new hope and healing to patients and families fighting cancer.”
This signing was officiated by Dr Preetha Reddy, Executive Vice Chairperson, Apollo Hospitals Enterprise Ltd (AHEL) and Olivier Legrain, Chief Executive Officer, IBA, in the distinguished presence of Princess Astrid of Belgium, Representative of King Philippe.
x
